NeuralCipher Research overview
The text below is the source article’s original abstract under a verified reuse license. cc0
A bstract Background Higher iron occurs in the substantia nigra in Parkinson’s disease (PD), but its behavior over time is poorly understood. Objective To determine if nigral iron measured by quantitative susceptibility MRI can track progression of early stages of PD. Methods Thirty-four early-stage PD patients (disease duration Results Of five clinic metrics and five regional iron measures, only MDS-UPDRS II (p = 0.046) and SNc iron (p = 0.004) showed significant changes for PD subjects in the one-year epoch. The changes of SNc iron also were correlated with changes of MDS-UPDRS II (p = 0.005). Conclusion Nigral iron content measured by zero-referencing is sensitive for tracking disease progression in early-stage PD.
Scientific assessment
Research question
Assess the question within the original study’s scope.
Methods & sample
Check the source article for study design and sample details.
Key findings
An editorially approved findings summary is not yet published for this record.
Limitations
Generalizability, bias and clinical meaning require separate assessment.
Methods, samples and clinical conclusions are not inferred from bibliographic metadata.